206 related articles for article (PubMed ID: 32627089)
41. B-cell posttransplant lymphoproliferative disorder isolated to the central nervous system is Epstein-Barr virus positive and lacks p53 and Myc expression by immunohistochemistry.
Sundin A; Grzywacz BJ; Yohe S; Linden MA; Courville EL
Hum Pathol; 2017 Mar; 61():140-147. PubMed ID: 27993575
[TBL] [Abstract][Full Text] [Related]
42. A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas.
van der Meeren LE; Kluiver J; Rutgers B; Alsagoor Y; Kluin PM; van den Berg A; Visser L
PLoS One; 2019; 14(10):e0223260. PubMed ID: 31603917
[TBL] [Abstract][Full Text] [Related]
43. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
Le Gouill S; Talmant P; Touzeau C; Moreau A; Garand R; Juge-Morineau N; Gaillard F; Gastinne T; Milpied N; Moreau P; Harousseau JL; Avet-Loiseau H
Haematologica; 2007 Oct; 92(10):1335-42. PubMed ID: 18024371
[TBL] [Abstract][Full Text] [Related]
44. EZH2 overexpression in primary gastrointestinal diffuse large B-cell lymphoma and its association with the clinicopathological features.
Liu Y; Yu K; Li M; Zeng K; Wei J; Li X; Liu Y; Zhao D; Fan L; Yu Z; Wang Y; Li Z; Zhang W; Bai Q; Yan Q; Guo Y; Wang Z; Guo S
Hum Pathol; 2017 Jun; 64():213-221. PubMed ID: 28438623
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system.
Sasagawa Y; Akai T; Tachibana O; Iizuka H
J Neurooncol; 2015 Jan; 121(1):177-83. PubMed ID: 25258254
[TBL] [Abstract][Full Text] [Related]
46. [Primary central nervous system diffuse large B cell lymphoma: a clinicopathologic and molecular study].
Ma ZP; Ainiwaer B; Liu ZY; Shi XL; Cui WL; Zhang W; Li XX
Zhonghua Bing Li Xue Za Zhi; 2016 Nov; 45(11):762-768. PubMed ID: 27821230
[No Abstract] [Full Text] [Related]
47. Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses.
Todorovic Balint M; Jelicic J; Mihaljevic B; Kostic J; Stanic B; Balint B; Pejanovic N; Lucic B; Tosic N; Marjanovic I; Stojiljkovic M; Karan-Djurasevic T; Perisic O; Rakocevic G; Popovic M; Raicevic S; Bila J; Antic D; Andjelic B; Pavlovic S
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164089
[TBL] [Abstract][Full Text] [Related]
48. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathological Characterization of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
Woo HY; Chae SW; DO SI; Na K
Anticancer Res; 2022 Nov; 42(11):5601-5608. PubMed ID: 36288864
[TBL] [Abstract][Full Text] [Related]
50. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
Staiger AM; Ziepert M; Horn H; Scott DW; Barth TFE; Bernd HW; Feller AC; Klapper W; Szczepanowski M; Hummel M; Stein H; Lenze D; Hansmann ML; Hartmann S; Möller P; Cogliatti S; Lenz G; Trümper L; Löffler M; Schmitz N; Pfreundschuh M; Rosenwald A; Ott G;
J Clin Oncol; 2017 Aug; 35(22):2515-2526. PubMed ID: 28525305
[TBL] [Abstract][Full Text] [Related]
51. Clinicopathological and fluorescence in situ hibridisation analysis of primary testicular diffuse large B-cell lymphoma: a single-centre case series.
Jovanovic MP; Mihaljevic B; Jovanovic P; Jelicic J; Martinovic VC; Jovanović J; Fekete MD; Čekerevac M; Bojanić N
Pol J Pathol; 2018; 69(2):136-142. PubMed ID: 30351860
[TBL] [Abstract][Full Text] [Related]
52. Pathology and new insights in central nervous system lymphomas.
Lebrun L; Allard-Demoustiez S; Salmon I
Curr Opin Oncol; 2023 Sep; 35(5):347-356. PubMed ID: 37439536
[TBL] [Abstract][Full Text] [Related]
53. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
[TBL] [Abstract][Full Text] [Related]
54. Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma.
Wang X; Cao X; Sun R; Tang C; Tzankov A; Zhang J; Manyam GC; Xiao M; Miao Y; Jabbar K; Tan X; Pang Y; Visco C; Xie Y; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WWL; van Krieken JH; Huh J; Ponzoni M; Ferreri AJM; Møller MB; Parsons BM; Winter JN; Piris MA; Li S; Miranda RN; Medeiros LJ; Li Y; Xu-Monette ZY; Young KH
Neoplasia; 2018 Jun; 20(6):574-593. PubMed ID: 29734016
[TBL] [Abstract][Full Text] [Related]
55. Microarray Gene-expression Profiling Analysis Comparing PCNSL and Non-CNS Diffuse Large B-Cell Lymphoma.
Lim DH; Kim WS; Kim SJ; Yoo HY; Ko YH
Anticancer Res; 2015 Jun; 35(6):3333-40. PubMed ID: 26026093
[TBL] [Abstract][Full Text] [Related]
56. Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence.
Magnes T; Wagner S; Thorner AR; Neureiter D; Klieser E; Rinnerthaler G; Weiss L; Huemer F; Zaborsky N; Steiner M; Weis S; Greil R; Egle A; Melchardt T
ESMO Open; 2021 Feb; 6(1):100012. PubMed ID: 33399078
[TBL] [Abstract][Full Text] [Related]
57. Primary central nervous system lymphomas and related diseases: Pathological characteristics and discussion of the differential diagnosis.
Sugita Y; Muta H; Ohshima K; Morioka M; Tsukamoto Y; Takahashi H; Kakita A
Neuropathology; 2016 Aug; 36(4):313-24. PubMed ID: 26607855
[TBL] [Abstract][Full Text] [Related]
58. C-MYC and BCL2 translocation frequency in diffuse large B-cell lymphomas: A study of 97 patients.
Akkaya B; Salim O; Akkaya H; Ozcan M; Yucel OK; Erdem R; Iltar U; Undar L
Indian J Pathol Microbiol; 2016; 59(1):41-6. PubMed ID: 26960633
[TBL] [Abstract][Full Text] [Related]
59. Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma.
Zheng M; Perry AM; Bierman P; Loberiza F; Nasr MR; Szwajcer D; Del Bigio MR; Smith LM; Zhang W; Greiner TC
Neuropathology; 2017 Dec; 37(6):509-516. PubMed ID: 28856744
[TBL] [Abstract][Full Text] [Related]
60. Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.
Swerdlow SH
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):90-9. PubMed ID: 25696840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
